Asthma and Facial paresis
Summary:
Facial paresis is found among people with Asthma, especially for people who are female, 50-59 old.
The study analyzes which people have Facial paresis with Asthma. It is created by eHealthMe based on reports of 86 people who have Asthma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Asthma?
Asthma is found to be associated with 2,095 drugs and 2,609 conditions by eHealthMe. Check the latest studies of Asthma.
What is Facial paresis?
Facial paresis (weakness in facial muscle movement) is found to be associated with 340 drugs and 936 conditions by eHealthMe. Check the latest studies of Facial paresis.
86 people who have Asthma and Facial Paresis are studied.

Gender of people who have Asthma and experienced Facial Paresis *:
- female: 90.48 %
- male: 9.52 %
Age of people who have Asthma and experienced Facial Paresis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 2.8200000000000003 %
- 20-29: 4.23 %
- 30-39: 4.23 %
- 40-49: 14.08 %
- 50-59: 42.25 %
- 60+: 32.39 %
Common co-existing conditions for these people *:
- Depression: 11 people, 12.79%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 11.63%
- Skin Wrinkling (wrinkle on skin): 10 people, 11.63%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 10.47%
- Pain: 9 people, 10.47%
- Osteoporosis (bones weak and more likely to break): 6 people, 6.98%
- Essential Hypertension (primary hypertension): 5 people, 5.81%
- Adjustment Disorder With Depressed Mood: 5 people, 5.81%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 5.81%
- Lung Cancer - Non-Small Cell (lung cancer): 5 people, 5.81%
Common drugs taken by these people *:
- Xolair: 30 people, 34.88%
- Ventolin: 28 people, 32.56%
- Spiriva: 23 people, 26.74%
- Norvasc: 19 people, 22.09%
- Amlodipine: 10 people, 11.63%
- Singulair: 10 people, 11.63%
- Botox: 9 people, 10.47%
- Advair Diskus 100/50: 9 people, 10.47%
- Tylenol: 9 people, 10.47%
- Symbicort: 9 people, 10.47%
Common symptoms for these people *:
- Headache (pain in head): 40 people, 46.51%
- Fatigue (feeling of tiredness): 38 people, 44.19%
- Weakness: 34 people, 39.53%
- Dyspnea (difficult or laboured breathing): 31 people, 36.05%
- Nausea (feeling of having an urge to vomit): 30 people, 34.88%
- Weight Decreased: 29 people, 33.72%
- High Blood Pressure: 28 people, 32.56%
- Arrhythmias (irregular heartbeat): 26 people, 30.23%
- Back Pain: 26 people, 30.23%
- Cough: 25 people, 29.07%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Facial paresis?
- Check whether Facial paresis is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Asthma (354,185 reports)
- Facial paresis (4,285 reports)
All the drugs that are associated with Facial paresis:
- Facial paresis (340 drugs)
All the conditions that are associated with Facial paresis:
- Facial paresis (936 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Facial paresis and Asthma, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Simcor and Lunesta - 3 seconds ago
- Pulmonary Tuberculosis Aggravated and Renal Failure Aggravated - 24 seconds ago
- Drug interactions of Dihydroergotamine Mesylate and Paroxetine - 24 seconds ago
- Drug interactions of Daliresp and Veramyst - 38 seconds ago
- Drug interactions of Liver and Naproxen - 40 seconds ago
- Drug interactions of Flexeril and Mometasone Furoate - 49 seconds ago
- Perivascular Dermatitis and drugs of ingredients of carbamazepine - 54 seconds ago
- Could Glimepiride cause Psychotic Disorder? - 58 seconds ago
- Could Para cause Swelling Face? - 58 seconds ago
- Kidney Stones and drugs of ingredients of burosumab-twza - 59 seconds ago